Contents
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents, Volume 2 - Number 4
Endostatin: Preclinical Development as an Anticancer Agent
, 2(4): 233 - 243T. Bachelot, R. Pawliuk and E. Jouanneau
DOI: 10.2174/1568013023358825
Genetic Lipodystrophies: Models for Insulin Resistance
, 2(4): 245 - 250Robert A. Hegele
DOI: 10.2174/1568013023358799
Recent Advances in the Diagnosis and Therapy of Primary Adrenal Insufficiency
, 2(4): 251 - 272Stefano Laureti, Fausto Santeusanio and Alberto Falorni
DOI: 10.2174/1568013023358780
Cerebral Hemorrhage Produced by Thrombolytic and Anti-Thrombotic Agents: A Review
, 2(4): 273 - 278Y. Suzuki, B. Q. Zhao and K. Umemura
DOI: 10.2174/1568013023358816
Inhibitor at the Gates, Inhibitor in the Chamber: Allosteric and Competitive Inhibitors of the Proteasome as Prospective Drugs
, 2(4): 279 - 301M. Gaczynska and P.A. Osmulski
DOI: 10.2174/1568013023358807
Webmaster Contact: info@benthamscience.org